MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 1142363-52-7
MCE 国际站:Edicotinib
产品活性:Edicotinib (JNJ-40346527) 是一种有效的、选择性的、具有血脑通透性和口服活性 CSF-1R 抑制剂,IC50 为 3.2 nM。Edicotinib 对 KIT 和 FLT3 的抑制作用较小,IC50 值分别为 20 nM 和 190 nM。Edicotinib 抑制小胶质细胞的扩张,减弱小胶质细胞的增殖和神经退行性变。Edicotinib 可以用于阿尔茨海默病和类风湿性关节炎的研究。
研究领域:Protein Tyrosine Kinase/RTK
作用靶点:c-Fms
In Vitro: Edicotinib (0.1 nM-1μM; 24 hours) Leads to a dose-dependent decrease of CSF1R activation and a concurrent reduction of ERK1 and ERK2 phosphorylation. The dose response curve shows the effect of JNJ-527 on CSF1R and ERK1/2, and the IC50 values are 18.6 nM and 22.5 nM for CSF1R and ERK1/2, respectively.
In Vivo: Edicotinib (oral gavage; 3, 10, 30 and 100 mg/kg; 5 days) significantly inhibits microglial proliferation in ME7 mice. It diminishes the number of microglia (total CD45+CD11b+ cells) only at the highest dose tested of 100 mg/kg, and JNJ-527 depletes up to 50% of patrolling blood monocytes at every dose tested (CD45+CD11bhighLy6Cintermediate/lowcells) with only a tendency for a reduction in the proportion of inflammatory monocytes (Ly6C high cells) at 100 mg/kg.Edicotinib exhibits a good pharmacokinetic/pharmacodynamics (PK/PD) profile, the microglial proliferation data shows an EC50 of 196/ml and 69 ng/g calculated from plasmatic and brain compound concentration, respectively.Edicotinib (oral gavage; 30 mg/kg; 33 days) significantly reduces the density of microglia in CA1 of the hippocampus of ME7-prion mice (PU.1+ cells) by up to 30%. And the expression of IL-1β is also reduced,but not other inflammatory cytokines.
相关产品:Covalent Screening Library Plus | Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Kinase Inhibitor Library | Protein Tyrosine Kinase Compound Library | Anti-Cancer Compound Library | Clinical Compound Library | CNS-Penetrant Compound Library | Drug Repurposing Compound Library | Covalent Screening Library | Pyroptosis Compound Library | Orally Active Compound Library | Anti-Alzheimer's Disease Compound Library | Neurodegenerative Disease-related Compound Library | Rare Diseases Drug Library | Anti-Prostate Cancer Compound Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Highly Selective Inhibitors Library | CSF1R-IN-12 | Pexidartinib | IACS-9439 | Namilumab | AZD7507 | Sotuletinib hydrochloride | c-Fms-IN-12 | c-Fms-IN-1 | Pazopanib-13C,d3 hydrochloride | Eflapegrastim | Cabiralizumab | PLX5622 | Otilimab | Plonmarlimab | CSF1R-IN-6 | c-Fms-IN-6 | Linifanib | RET-IN-19 | CSF1R-IN-8 | BPR1R024 mesylate | Lacnotuzumab | cFMS Receptor Inhibitor II | CSF1R-IN-15 | Gimsilumab | Dovitinib-d8 | Vimseltinib | JTE-952 | Axl/Mer/CSF1R-IN-1
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
货号: HY-109086
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。